Novel pyridine derivatives as potassium ion channel openers

Details for Australian Patent Application No. 2006216566 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Jain, Nareshkumar; Sui, Zhihua; Xu, Jiayi

Agent Shelston IP

Pub. Number AU-A-2006216566

PCT Pub. Number WO2006/091800

Priority 60/655,765 24.02.05 US

Filing date 23 February 2006

Wipo publication date 31 August 2006

International Classifications

C07D 213/30 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/44 (2006.01) - Non-condensed pyridines

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

C07D 491/04 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

Event Publications

23 August 2007 PCT application entered the National Phase

  PCT publication WO2006/091800 Priority application(s): WO2006/091800

15 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006216567-Methods for treating ocular angiogenesis, retinal edema, retinal ischemia, and diabetic retinopathy using selective RTK inhibitors

2006216558-Composite pre-formed building panels, a building and a framing stud